Furthermore, lower expression of TSP50 also decreased the ADR pumping rate, drug resistance protein levels, and the sensitivity of breast cancer cells to ADR was enhanced (Fig. 4M-O, Fig. S3O-Q). The gene discussed is PRSS50; the disease is breast carcinoma.